Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06317428
Status:
RECRUITING
Last Update Posted:
2024-03-19
First Post:
2024-03-12
Brief Title:
NT-proBNP Levels During Triple Therapy With FormoterolGlycopyrrolateBudesonide in Patients With COPD
Sponsor:
Istituto Nazionale di Ricovero e Cura per Anziani
Organization:
Istituto Nazionale di Ricovero e Cura per Anziani
Study Overview
Official Title:
Change in Serum Levels of NT-proBNP During Triple Therapy With FormoterolGlycopyrrolateBudesonide in Patients With COPD
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NTproBNP
Brief Summary:
Observational prospective study to evaluate serum NT-proBNP levels in a population of COPD patients three months after the iniation of triple inhaled formoterolglycopyrrolatebudesonide therapy
Detailed Description:
The purpose of the trixeo study is to conduct a prospective observational study to evaluate serum NT-proBNP levels in a population of COPD patients three months after the initiation of triple inhaled formoterolglycopyrrolatebudesonide therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None